Sunitinib Malate Capsule
Product Images NDC 63304-092

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sunitinib Malate (NDC 63304-092). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-sunitinib-25mg-label (Spl Sunitinib 25mg Label)

Sunitinib Malate Capsules 25 mg label showing the product name, strength, dosage form, and quantity of 28 capsules. The label includes manufacturer information for Sun Pharmaceutical Industries Inc., instructions for the pharmacist to dispense accompanying Medication Guide, NDC number 63304-092-27, and a barcode. The label also provides storage instructions and a child safety warning.*

FDA Label Image

Spl-sunitinib-50mg-label (Spl Sunitinib 50mg Label)

Sunitinib Malate Capsules 50 mg label from Sun Pharmaceutical Industries Inc. The label states 'Rx only' and a package size of 28 capsules. It includes storage instructions to keep the capsules at 20°C to 25°C, avoid moisture, and keep out of reach of children. Additional notes highlight the medication guide is to be dispensed to each patient and references the Sunitinib DATA SHEET.*

FDA Label Image

Spl-sunitinib-capsules-label1 (Spl Sunitinib Capsules Label1)

Label for Sunitinib Malate Capsules 12.5 mg by Sun Pharmaceutical Industries Inc., containing 28 oral capsules. The label includes dosing information, storage instructions, a barcode, and a warning to keep out of reach of children. It specifies the product is prescription only and emphasizes pharmacist dispensing instructions.*

FDA Label Image

Spl-sunitinib-capsules-label3 (Spl Sunitinib Capsules Label3)

Label for Sunitinib Malate capsules, 37.5 mg strength, oral dosage form. The label specifies 28 capsules per container and is manufactured by Sun Pharmaceutical Industries Inc. Directions include dispensing an accompanying Medication Guide. The label also contains storage instructions and a barcode, along with the NDC number 63304-093-27.*

FDA Label Image

Spl-sunitinib-figure1 (Spl Sunitinib Figure1)

A Kaplan-Meier survival curve chart showing time to tumor progression in weeks for Sunitinib compared to placebo. The chart presents the probability of tumor progression over time, with Sunitinib showing a longer median time to progression than placebo.*

FDA Label Image

Spl-sunitinib-figure2 (Spl Sunitinib Figure2)

A Kaplan-Meier survival curve comparing progression-free survival probability (%) over time (weeks) between two groups: Sunitinib (N=375) with a median of 47.3 weeks and IFN-alpha (N=375) with a median of 22.0 weeks. The graph includes hazard ratio, confidence interval, p-value, and number of subjects at risk at various time points up to 60 weeks.*

FDA Label Image

Spl-sunitinib-figure3 (Spl Sunitinib Figure3)

A Kaplan-Meier survival curve chart comparing disease-free survival probability over time in years for two groups: Sunitinib (n=309) and Placebo (n=306). The chart shows survival probability on the y-axis and time in years on the x-axis, with Sunitinib demonstrating a median disease-free survival of 6.8 years and Placebo 5.6 years. The hazard ratio, confidence interval, and p-value are also displayed.*

FDA Label Image

Spl-sunitinib-figure4 (Spl Sunitinib Figure4)

A Kaplan-Meier survival curve chart depicting progression-free survival probability over time (months) for two groups: Sunitinib (N=86) and Placebo (N=85). The chart shows higher survival probability for the Sunitinib group, with median survival of 10.2 months compared to 5.4 months for Placebo. The hazard ratio is 0.427 with 95% confidence interval 0.271 to 0.673 and p-value 0.000146.*

FDA Label Image

Spl-sunitinib-malate-structure (Spl Sunitinib Malate Structure)

Chemical structure of sunitinib malate shown as a detailed 2D molecular diagram, displaying atoms including fluorine, carbon, nitrogen, oxygen, and hydrogen arranged to represent the full molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.